Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-04-029620
Filing Date
2004-06-03
Accepted
2004-06-03 18:37:28
Documents
1
Period of Report
2004-06-02

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION bsf99362_1ns.html 4  
1 MAIN DOCUMENT DESCRIPTION bsf99362_1ns.xml 4 4100
  Complete submission text file 0001209191-04-029620.txt   5832
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SANGSTAT MEDICAL CORP 6300 DUMBARRTON CIRCLE FREMONT CA 94555
Business Address
SIMON NICHOLAS J III (Reporting) CIK: 0001221595 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29889 | Film No.: 04848210